Anticancer metallodrugs based on ruthenium and osmium are among the most investigated
and advanced non-platinum metallodrugs. Inorganic drug discovery with these agents has …

Polyoxometalates (POMs) are discrete anionic metaloxygen clusters which can be regarded
as soluble oxide fragments. They exhibit a great diversity of sizes, nuclearities, and shapes …

Light driven water splitting was achieved by a tandem dye-sensitized photoelectrochemical
cell with two photoactive electrodes. The photoanode is constituted by an organic dye L0 as …

The well-developed synthetic chemistry of ruthenium, particularly with ammine, amine and
imine ligands, provides for many approaches to innovative new metallopharmaceuticals …

Neutral or cationic arene ruthenium complexes providing both hydrophilic as well as
hydrophobic properties due to the robustness of the ruthenium–arene unit hold a high …

Sulfoxides are capable of forming stable complexes with transition metals and there have
been many comprehensive studies into their binding properties. However, the use of …

Despite the resounding success of cisplatin and closely related platinum antitumor agents, 1-
3 the movement of other transition-metal antitumor agents toward the clinic has been …

Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH+)[RuIIICl4
(Im)(S-dmso)], where Im= imidazole and S-dmso= S-bound dimethylsulfoxide) or KP1019 …

An extensive survey of the occurrences and origins of both structural trans-effects (STEs)
and kinetic trans-effects (KTEs) in octahedral d-transition metal complexes is presented. This …

Ruthenium‐based anticancer chemotherapies are making significant advances in clinical
trials. Until recently, the focus has been on coordination complexes, and mechanisms such …